Congo vs Lesotho: Cause of death, by non-communicable diseases, ages 60+, female
Congo
61.4%
in 2021
Lesotho
61.1%
in 2021
Congo rank
161st
Lesotho rank
162nd
Cause of death, by non-communicable diseases, ages 60+, female over time
- Congo
- Lesotho
How they compare
Congo currently reports 61.4% against 61.1% in Lesotho, a difference of 0.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Congo ahead.
Congo ranks 161st and Lesotho ranks 162nd of 185 countries.
Across the 3 decades both report, Congo averaged higher in 1 and Lesotho in 2.
Head to head by decade
| Decade | Congo | Lesotho | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.3% | 61.1% | 13.2% | Congo |
| 2010s | 70.0% | 70.4% | 0.4% | Lesotho |
| 2020s | 62.9% | 66.8% | 3.9% | Lesotho |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Congo or Lesotho?
- Congo, at 61.4% against 61.1% in Lesotho as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Congo and Lesotho?
- 0.3%, with Congo ahead.
- How many years of comparable data are there for Congo and Lesotho?
- 6 years are reported by both, from 2000 to 2021.
- How do Congo and Lesotho rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Congo ranks 161st and Lesotho ranks 162nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.